3Q2023 Financial Summary - En Statement of Comprehensive Income (Consolidated) (Unit : Million Baht) Q3/2022 Q3/2023 Increase (Decrease) %YoY 9M2022 9M2023 Increase (Decrease) %YoYAmount % Amount
decreased by 17.22% 2023 Financial Summary Financial performance of Advice IT Infinite Public Company Limited and its subsidiaries, as per the consolidated financial statements for 2023, compared to 2022, is
consolidated financial statements of Q1/2024 compared to the same period of the year 2023, is as follows: Total Revenue amounted to THB 3,568.38 million increased by 3.23% Gross Profit amounted to THB 334.25
Company according to the consolidated financial statement of the Company ended 30 September 2013 which is more than THB 20 million or 3 percent of NTA of the Company pursuant to Notification of Capital
Consolidated Financial Statement of the Company for the period ending 30 September 2017 which was reviewed by the certified public accountant. In this regard, there were no other asset disposal transactions of
) Consolidated The Company only ( 20..) ( 20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under reverse repurchase agreement 4. Investments
20.. Assets (Unit:Baht) Consolidated The Company only (20..) (20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under reverse
) ………………………………….20.. and 20.. Assets (Unit:Baht) Consolidated The Company only (20..) (20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under
), and Andreas Rizal Vourloumis (holds 18.625 percent voting rights) collectively hold equity voting shares in SSG CH in an aggregate amount of 100 percent. SSG CH owns 100 percent equity voting shares in
statements comprise of the consolidated financial statements and the separate financial statements as compared with the financial statements for year 2016 ended December 31, 2016. The Company’s overall